rMalaria (P.v. CSP) Antigens - Infectious Disease
- Known as:
- rMalaria (P.v. CSP) Antigens - Infectious Disease
- Catalog number:
- AGMAL-0220
- Product Quantity:
- 1-99 mg/ml/ea price
- Category:
- -
- Supplier:
- Arista Bio
- Gene target:
- rMalaria (.. CSP) Antigens - Infectious Disease
Related genes to: rMalaria (P.v. CSP) Antigens - Infectious Disease
- Gene:
- ACAN NIH gene
- Name:
- aggrecan
- Previous symbol:
- MSK16, CSPG1, AGC1
- Synonyms:
- CSPGCP
- Chromosome:
- 15q26.1
- Locus Type:
- gene with protein product
- Date approved:
- 1992-06-17
- Date modifiied:
- 2013-05-07
- Gene:
- BCAN NIH gene
- Name:
- brevican
- Previous symbol:
- -
- Synonyms:
- BEHAB, MGC13038, CSPG7
- Chromosome:
- 1q23.1
- Locus Type:
- gene with protein product
- Date approved:
- 2004-03-01
- Date modifiied:
- 2016-10-05
- Gene:
- CD44 NIH gene
- Name:
- CD44 molecule (Indian blood group)
- Previous symbol:
- MIC4, MDU2, MDU3
- Synonyms:
- IN, MC56, Pgp1, CD44R, HCELL, CSPG8
- Chromosome:
- 11p13
- Locus Type:
- gene with protein product
- Date approved:
- 1989-06-30
- Date modifiied:
- 2019-04-23
- Gene:
- CSPG4 NIH gene
- Name:
- chondroitin sulfate proteoglycan 4
- Previous symbol:
- -
- Synonyms:
- MCSPG, MEL-CSPG, MSK16, NG2, MCSP, HMW-MAA
- Chromosome:
- 15q24.2
- Locus Type:
- gene with protein product
- Date approved:
- 1997-11-28
- Date modifiied:
- 2014-11-18
- Gene:
- CSPG4P1Y NIH gene
- Name:
- CSPG4 pseudogene 1 Y-linked
- Previous symbol:
- CSPG4LYP1, CSPG4P1
- Synonyms:
- -
- Chromosome:
- Yq11.23
- Locus Type:
- pseudogene
- Date approved:
- 2001-09-21
- Date modifiied:
- 2018-04-26
Related products to: rMalaria (P.v. CSP) Antigens - Infectious Disease
(DRAAGQPAG)3 (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) control blocking peptide(DRAAGQPAG)3 peptide (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) conjugated with BSA(DRADGQPAG)3 peptide (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP), pure(NANP)10 (40-aa NANP repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) peptide, pure(NANP)5 peptide (25-aa, repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA(NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control blocking peptide(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control blocking peptide(PAPPNAAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) conjugated with BSA(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control blocking peptide(PPPPNPPND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure47 kDa autosomal chronic granulomatous disease protein,47 kDa neutrophil oxidase factor,Homo sapiens,Human,NCF1,NCF-1,NCF-47K,Neutrophil cytosol factor 1,Neutrophil NADPH oxidase factor 1,Nox organize71B10,Mouse,Mus musculus,PC1-like 3 protein,Pkd1l3,Polycystic kidney disease protein 1-like 3,Polycystin-1L3Escherichia coli<_i> (O_K antigens) polyclonal antibody